P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 22 April 2019 | 1:12 pm

Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis

INDIANAPOLIS, April 22, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Taltz more ...

Published 22 April 2019 | 12:41 pm

Lilly and Avidity Biosciences Announce Licensing and Research Collaboration

-Collaboration will pursue therapeutic targets focused on immunology and other indications -Avidity to receive an upfront payment of $20 million and an investment of $15 more ...

Published 22 April 2019 | 10:06 am

CEO Christophe Weber on Why Takeda's Unique Corporate Governance Structure Works

How a decentralized approach and an independent board are driving Takeda's success. more ...

Published 19 April 2019 | 9:00 pm

A PUBLIC HEALTH SUCCESS STORY

Vaccines are one of the greatest public health success stories of the last two centuries. more ...

Published 19 April 2019 | 5:54 pm

Using "Molecular Glues" to Hijack the Body's Garbage Disposal System

Using "Molecular Glues" to Hijack the Body's Garbage Disposal System more ...

Published 19 April 2019 | 4:15 pm

Hope in Translation: Bringing Gene Therapy to the Clinic

Hope in Translation: Bringing Gene Therapy to the Clinic more ...

Published 19 April 2019 | 9:44 am

Our Responsibilities for the Future

We are people, patients, parents, caregivers, researchers... Together, we are Sanofi, a healthcare organization dedicated to improving the lives of people worldwide. Our teams more ...

Published 18 April 2019 | 11:49 pm

Press Release Archives

Pfizer and Lilly Announce Top-Line Results from Long-Term Phase 3 Study of Tanezumab in Patients with Osteoarthritis more ...

Published 18 April 2019 | 11:21 pm

Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis

)-- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective more ...

Published 18 April 2019 | 10:15 pm

Gilead Sciences to Release First Quarter 2019 Financial Results on Thursday, May 2, 2019

FOSTER CITY, Calif. --(BUSINESS WIRE)--Apr. 18, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2019 financial results will be released on more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018